Skip to main content
PMC home page
The BMJ logoLink to The BMJ
editorial
. 1991 Jan 5;302(6767):4–5. doi: 10.1136/bmj.302.6767.4

Cyclosporin: use outside transplantation.

A W Thomson, G H Neild
PMCID: PMC1668781  PMID: 1991188

Full text

PDF
4

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borel J. F. Pharmacology of cyclosporine (sandimmune). IV. Pharmacological properties in vivo. Pharmacol Rev. 1990 Sep;41(3):259–371. [PubMed] [Google Scholar]
  2. Brynskov J., Freund L., Rasmussen S. N., Lauritsen K., de Muckadell O. S., Williams N., MacDonald A. S., Tanton R., Molina F., Campanini M. C. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med. 1989 Sep 28;321(13):845–850. doi: 10.1056/NEJM198909283211301. [DOI] [PubMed] [Google Scholar]
  3. Crabtree G. R. Contingent genetic regulatory events in T lymphocyte activation. Science. 1989 Jan 20;243(4889):355–361. doi: 10.1126/science.2783497. [DOI] [PubMed] [Google Scholar]
  4. Gallagher R. B., Cambier J. C. Signal transmission pathways and lymphocyte function. Immunol Today. 1990 Jun;11(6):187–189. doi: 10.1016/0167-5699(90)90078-n. [DOI] [PubMed] [Google Scholar]
  5. Granelli-Piperno A. Lymphokine gene expression in vivo is inhibited by cyclosporin A. J Exp Med. 1990 Feb 1;171(2):533–544. doi: 10.1084/jem.171.2.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ryffel B. Pharmacology of cyclosporine. VI. Cellular activation: regulation of intracellular events by cyclosporine. Pharmacol Rev. 1990 Sep;41(3):407–422. [PubMed] [Google Scholar]
  7. Starzl T. E., Todo S., Fung J., Demetris A. J., Venkataramman R., Jain A. FK 506 for liver, kidney, and pancreas transplantation. Lancet. 1989 Oct 28;2(8670):1000–1004. doi: 10.1016/s0140-6736(89)91014-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Tindall R. S., Rollins J. A., Phillips J. T., Greenlee R. G., Wells L., Belendiuk G. Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. N Engl J Med. 1987 Mar 19;316(12):719–724. doi: 10.1056/NEJM198703193161205. [DOI] [PubMed] [Google Scholar]
  9. Tugwell P., Bombardier C., Gent M., Bennett K. J., Bensen W. G., Carette S., Chalmers A., Esdaile J. M., Klinkhoff A. V., Kraag G. R. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet. 1990 May 5;335(8697):1051–1055. doi: 10.1016/0140-6736(90)92630-z. [DOI] [PubMed] [Google Scholar]
  10. Wiesner R. H., Ludwig J., Lindor K. D., Jorgensen R. A., Baldus W. P., Homburger H. A., Dickson E. R. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. N Engl J Med. 1990 May 17;322(20):1419–1424. doi: 10.1056/NEJM199005173222003. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES